Skip to main content

Find Clinical Trials

Home
Conditions
C-met Overexpression

Clinical trial condition

C-met Overexpression

Explore clinical trials studying C-met Overexpression. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

C-met Overexpression trial results

Completed

Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects

NCT01892527

Conditions: C-met Overexpression, Colorectal Cancer Metastatic
Locations: Istituto Clinico Humanitas Rozzano, Milano, Italy

View Trial Details

Colorectal Cancer Metastatic (1)